post-exposure-prophylaxis

Documents about post-exposure-prophylaxis

• Survey of Human Rabies Immune Globulin Safety in Children#852369ClinicalTrials.gov
• Survey on the current status of rabies post-exposure prophylaxis clinics construction and the surveillance of rabies-exposed individuals in China, 2022#302067PLOS
• Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.#833714ClinicalTrials.gov
• Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland#892248ClinicalTrials.gov
• Données du système d’information sanitaire de routine et des établissements de santé sur les maladies tropicales négligées : rage#129084WHO IRIS
• Practitioner’s perspectives on access to Rabies Post-Exposure Prophylaxis in Tanzania: A mixed-methods and theoretically-informed study to inform policy and practice#186363PLOS
• A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects#867912ClinicalTrials.gov
• Profilaxia pós-exposição da raiva humana em Sergipe, Brasil: evidências epidemiológicas e espaço-temporais para a gestão do risco e a vigilância em saúde#462216Repositório Institucional da Universidade Federal de Sergipe
• Responding to children and adolescents who have been sexually abused: WHO clinical guidelines: web Annex 3a: adherence to HIV post-exposure prophylaxis: evidence-to-decision table#422117WHO IRIS
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients#830009ClinicalTrials.gov